Peripartum mood disturbances primary prevention

Peripartum mood disturbances Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Peripartum mood disturbances from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Peripartum mood disturbances primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Peripartum mood disturbances primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Peripartum mood disturbances primary prevention

CDC on Peripartum mood disturbances primary prevention

Peripartum mood disturbances primary prevention in the news

Blogs on Peripartum mood disturbances primary prevention

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Peripartum mood disturbances primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Sunita Kumawat, M.B.B.S[2]

## Overview[edit | edit source]

Effective measures for the primary prevention of Peripartum mood disturbances include biological, psychological, and psychosocial.

## Primary Prevention[edit | edit source]

Effective measures for the primary prevention of Peripartum mood disturbances include:[1]

Biological intervention-

* Psychotropic medicines: Sertraline was shown to be substantially more effective compared to placebo in avoiding depression recurrence.
* Reproductive hormones: High-dose estrogen has been shown to reduce the risk of recurrence.

* Micronutrients: Omega-3 fatty acids, fish oil rich in docosahexaenoic acid, DHA and AA(Arachidonic acid)

* Other biological agents: thyroxine, dietary calcium, and selenium.

Psychological and psychosocial methods

* Psychological intervention: Interpersonal therapy, Cognitive Behavioral therapy, Postnatal Psychological Debriefing

* Psychosocial interventions: Antenatal and Postnatal Classes, Postnatal support.

## References[edit | edit source]

1. ↑ Werner E, Miller M, Osborne LM, Kuzava S, Monk C (February 2015). "Preventing postpartum depression: review and recommendations". Arch Womens Ment Health. 18 (1): 41–60. doi:10.1007/s00737-014-0475-y. PMC 4308451. PMID 25422150.

Template:WH Template:WS